1. Home
  2. ILMN vs PBA Comparison

ILMN vs PBA Comparison

Compare ILMN & PBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • PBA
  • Stock Information
  • Founded
  • ILMN 1998
  • PBA 1997
  • Country
  • ILMN United States
  • PBA Canada
  • Employees
  • ILMN N/A
  • PBA N/A
  • Industry
  • ILMN Medical Specialities
  • PBA Oil & Gas Production
  • Sector
  • ILMN Health Care
  • PBA Energy
  • Exchange
  • ILMN Nasdaq
  • PBA Nasdaq
  • Market Cap
  • ILMN 22.9B
  • PBA 24.0B
  • IPO Year
  • ILMN 2000
  • PBA N/A
  • Fundamental
  • Price
  • ILMN $141.09
  • PBA $39.45
  • Analyst Decision
  • ILMN Buy
  • PBA Buy
  • Analyst Count
  • ILMN 20
  • PBA 1
  • Target Price
  • ILMN $160.68
  • PBA $57.00
  • AVG Volume (30 Days)
  • ILMN 2.1M
  • PBA 1.2M
  • Earning Date
  • ILMN 11-04-2024
  • PBA 11-05-2024
  • Dividend Yield
  • ILMN N/A
  • PBA 5.05%
  • EPS Growth
  • ILMN N/A
  • PBA 51.43
  • EPS
  • ILMN N/A
  • PBA 2.43
  • Revenue
  • ILMN $4,390,000,000.00
  • PBA $7,305,229,650.00
  • Revenue This Year
  • ILMN N/A
  • PBA N/A
  • Revenue Next Year
  • ILMN $4.28
  • PBA $15.54
  • P/E Ratio
  • ILMN N/A
  • PBA $16.72
  • Revenue Growth
  • ILMN N/A
  • PBA 37.18
  • 52 Week Low
  • ILMN $97.36
  • PBA $32.39
  • 52 Week High
  • ILMN $156.66
  • PBA $43.44
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 48.42
  • PBA 33.12
  • Support Level
  • ILMN $138.88
  • PBA $39.88
  • Resistance Level
  • ILMN $144.00
  • PBA $40.58
  • Average True Range (ATR)
  • ILMN 4.58
  • PBA 0.71
  • MACD
  • ILMN -0.05
  • PBA -0.24
  • Stochastic Oscillator
  • ILMN 69.62
  • PBA 3.73

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About PBA Pembina Pipeline Corp. (Canada)

Pembina Pipeline is a midstream company serving the Canadian and North American (primarily Bakken) markets with an integrated product portfolio. Its assets include pipelines and gas gathering as well as assets across fractionation, storage, and propane exports.

Share on Social Networks: